Lunai Bioworks Inc.

LNAI | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.30

-$0.03 (-1.29%)

At close: Sep 21, 2026, 4:00 PM ET

$2.12

-$0.18 (-7.83%)

Pre-market: Sep 22, 2026, 4:48 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-1.29%

(1D)

Rating

Updated: Aug 29, 2026

34.5

Fundamentals Weak

Market Sentiment Neutral

Moat Wide

Full Analysis

Key Statistics

Market Data

Market Cap $10.43M

1D Range

2.23 2.41

52W Range

1.21 14.40

Valuation (TTM)

PE -0.04

PB -1.09

EV/EBITDA -0.89

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target N/A

Cash Flow

FCF Yield -50.4%

SBC Adj. FCF Yield -60.8%

SBC Impact -20.5%

Margins

Gross Margin -360.7%

Operating Margin -46992.0%

FCF Margin -25114.9%

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -20.5% | N/A

FCF 3Y | 5Y 19.2% | N/A

Returns

ROA -1301.0%

ROE 892.5%

ROIC 120.9%

Financial Health

Net Cash

$1.88M

Current Ratio 0.19

Interest Coverage -16.23

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological d...

Sector Healthcare

Industry Biotechnology

Employees 29

IPO Date Sep 29, 2025

Website www.lunaibioworks.com

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.